Abstract:Cell-intrinsic reporters such as luciferase (LUC) and red fluorescent protein (RFP) have been commonly utilized in preclinical studies to image tumor growth and to monitor therapeutic responses. While extrinsic reporters that emit near infrared I (NIR-I: 650-950 nm) or near-infrared II (NIR-II: 1000 -1700 nm) optical signals have enabled minimization of tissue autofluorescence and light scattering, it has remained unclear as to whether their use has afforded more accurate tumor imaging in small animals. Here, we developed a novel optical imaging construct comprised of rare earth lanthanide nanoparticles coated with biodegradable diblock copolymers and doped with organic fluorophores, generating NIR-I and NIR-II emissive bands upon optical excitation. Simultaneous injection of multiple spectrally-unique nanoparticles into mice bearing tumor implants established via intraperitoneal dissemination of LUC+/ RFP+ OVCAR-8 ovarian cancer cells enabled direct comparisons of imaging with extrinsic vs. intrinsic reporters, NIR-II vs. NIR-I signals, as well as targeted vs. untargeted exogenous contrast agents in the same animal and over time. We discovered that in vivo optical imaging at NIR-II wavelengths facilitates more accurate detection of smaller and earlier tumor deposits, offering enhanced sensitivity, improved spatial contrast, and increased depths of tissue penetration as compared to imaging with visible or NIR-I fluorescent agents. Our work further highlights the hitherto underappreciated enhancements in tumor accumulation that may be achieved with intraperitoneal as opposed to intravenous administration of nanoparticles. Lastly, we found discrepancies in the fidelity of tumor uptake that could be obtained by utilizing small molecules for in vivo as opposed to in vitro targeting of nanoparticles to disseminated tumors. (C) 2017 Elsevier Ltd. All rights reserved.

Ultrasmall near-infrared gold nanoclusters for tumor fluorescence imaging in vivo.

Ultra-Small and Metabolizable Near-Infrared Au/Gd Nanoclusters for Targeted FL/MRI Imaging and Cancer Theranostics

Early Tumor Detection Afforded by in Vivo Imaging of Near-Infrared Ii Fluorescence

Luminescent Gold Nanoclusters for in Vivo Tumor Imaging

Gold Nanoclusters for Tumor Diagnosis and Treatment

In Vivo Self-Bio-imaging of Tumors Through in Situ Biosynthesized Fluorescent Gold Nanoclusters.

Gold Nanoclusters As Novel Optical Probes for in Vitro and in Vivo Fluorescence Imaging.

Cerenkov Luminescence Transfer Based Gold-198 Nanocluster for Tumor in Vivo Imaging and Therapy

Rapid tumor bioimaging and photothermal treatment based on GSH-capped red fluorescent gold nanoclusters

Rapid synthesis of highly luminescent and stable Au20 nanoclusters for active tumor-targeted imaging in vitro and in vivo.

Folate-modified gold nanoclusters as near-infrared fluorescent probes for tumor imaging and therapy.

Title: Advances of Gold Nanoclusters for Bioimaging

Ultrasmall bimodal Nanomolecules enhanced tumor angiogenesis contrast with endothelial cell targeting and molecular pharmacokinetics.

Gold nanoflowers for 3D volumetric molecular imaging of tumors by photoacoustic tomography

Cytidine Mediated AuAg Nanoclusters as Bright Fluorescent Probe for Tumor Imaging in vivo

Gold Nanoclusters As Contrast Agents for Fluorescent and X-ray Dual-Modality Imaging.

Advances of Gold Nanoclusters for Bioimaging

In vivo tumor ultrasound-switchable fluorescence imaging via intravenous injections of size-controlled thermosensitive nanoparticles

Atomic‐Precision Gold Clusters for NIR‐II Imaging

Near-Infrared II Gold Nanocluster Assemblies with Improved Luminescence and Biofate for In Vivo Ratiometric Imaging of H<sub>2</sub>S

Characterization of a fluorescence probe based on gold nanoclusters for cell and animal imaging